Yeast surface display for protein engineering and characterization

Current Opinion in Structural Biology

Volumn 17, Issue 4, 2007, Pages 467-473

  Gai, S Annie ^a   Wittrup, K Dane ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; EPITOPE; PROTEIN;

BINDING AFFINITY; BIOTECHNOLOGY; EPITOPE MAPPING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ENGINEERING; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; YEAST SURFACE DISPLAY;

ANIMALS; ENZYMES, IMMOBILIZED; HUMANS; PEPTIDE LIBRARY; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN INTERACTION MAPPING; SACCHAROMYCES CEREVISIAE; SOLUBILITY;

EID: 34648832245     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2007.08.012     Document Type: Review

References (65)

1. Boder E.T., and Wittrup K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 15 (1997) 553-557
2. Chao G., Lau W.L., Hackel B.J., Sazinsky S.L., Lippow S.M., and Wittrup K.D. Isolating and engineering human antibodies using yeast surface display. Nat Protoc 1 (2006) 755-768. This paper provides a detailed and comprehensive protocol for engineering proteins by yeast surface display. While the focus is on isolating and engineering scFvs, the procedures are applicable for engineering any protein that can be displayed by yeast and whose binding target is available in soluble form.
3. Bowley D.R., Labrijn A.F., Zwick M.B., and Burton D.R. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage. Protein Eng Des Sel 20 (2007) 81-90. This study offers the first direct comparison of yeast surface display and phage display. From identical libraries, screened with the same antigen, yeast display was found to identify many more high-affinity clones and also required less effort. These two significant advantages of yeast display were attributed to, respectively, eukaryotic processing and flow-cytometry-based library screening and clone analysis.
4. Bidlingmaier S., and Liu B. Construction and application of a yeast surface-displayed human cDNA library to identify post-translational modification-dependent protein-protein interactions. Mol Cell Proteomics 5 (2006) 533-540
5. Mischo A., Kubuschok B., Ertan K., Preuss K.-D., Romeike B., Regitz E., Schormann C., de Bruijn D., Wadle A., Neumann F., et al. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer. Int J Cancer 118 (2006) 696-703
6. Wadle A., Kubuschok B., Imig J., Wüllner B., Wittig C., Zwick C., Mischo A., Wätzig K., Romeike B.F.M., Lindemann W., et al. Serological immune response to cancer testis antigens in patients with pancreatic cancer. Int J Cancer 119 (2006) 117-125
7. Wadle A., Mischo A., Imig J., Wüllner B., Hensel D., Wätzig K., Neumann F., Kubuschok B., Schmidt W., Old L.J., et al. Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library. Int J Cancer 117 (2005) 104-113
8. Lee H.-W., Lee S.-H., Park K.-J., Kim J.-S., Kwon M.-H., and Kim Y.-S. Construction and characterization of a pseudo-immune human antibody library using yeast surface display. Biochem Biophys Res Commun 346 (2006) 896-903
9. Scholler N., Garvik B., Quarles T., Jiang S., and Urban N. Method for generation of in vivo biotinylated recombinant antibodies by yeast mating. J Immunol Methods 317 (2006) 132-143
10. Weaver-Feldhaus J.M., Miller K.D., Feldhaus M.J., and Siegel R.W. Directed evolution for the development of conformation-specific affinity reagents using yeast display. Protein Eng Des Sel 18 (2005) 527-536
11. Wang X.X., Cho Y.K., and Shusta E.V. Mining a yeast library for brain endothelial cell-binding antibodies. Nat Methods 4 (2007) 143-145
12. Peelle B.R., Krauland E.M., Wittrup K.D., and Belcher A.M. Probing the interface between biomolecules and inorganic materials using yeast surface display and genetic engineering. Acta Biomater 1 (2005) 145-154
13. Rajpal A., Beyaz N., Haber L., Cappuccilli G., Yee H., Bhatt R.R., Takeuchi T., Lerner R.A., and Crea R. A general method for greatly improving the affinity of antibodies by using combinatorial libraries. Proc Natl Acad Sci USA 102 (2005) 8466-8471
14. Wang Z., Kim G.-B., Woo J.-H., Liu Y.Y., Mathias A., Stavrou S., and Neville D.M. Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv. Bioconjugate Chem 18 (2007) 947-955
15. Razai A., Garcia-Rodriguez C., Lou J., Geren I.N., Forsyth C.M., Robles Y., Tsai R., Smith T.J., Smith L.A., Siegel R.W., et al. Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A. J Mol Biol 351 (2005) 158-169
16. Garcia-Rodriguez C., Levy R., Arndt J.W., Forsyth C.M., Razai A., Lou J., Geren I., Stevens R.C., and Marks J.D. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat Biotechnol 25 (2007) 107-116. This study illustrates the use of yeast surface display for selectively expanding antibody reactivity. Starting from a scFv that recognizes botulinum neurotoxin type A1 with high affinity, the authors identified a mutant that recognizes type A2 with high affinity as well. Notably, the selection process required independent and simultaneous quantification of binding to both target antigens, which was enabled by cell-surface display and flow cytometry.
17. Koide A., Gilbreth R.N., Esaki K., Tereshko V., and Koide S. High-affinity single-domain binding proteins with a binary-code interface. Proc Natl Acad Sci USA 104 (2007) 6632-6637. In this work, fibronectin scaffold binders with only tyrosine and serine in their variable loops were identified by first screening a phage-displayed library, followed by a yeast-displayed library for fine affinity discrimination.
18. Lipovsek D., Lippow S.M., Hackel B.J., Gregson M.W., Cheng P., Kapila A., and Wittrup K.D. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies. J Mol Biol 368 (2007) 1024-1041
19. Jin M., Song G., Carman C.V., Kim Y.-S., Astrof N.S., Shimaoka M., Wittrup D.K., and Springer T.A. Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity. Proc Natl Acad Sci USA 103 (2006) 5758-5763
20. Cochran J.R., Kim Y.-S., Lippow S.M., Rao B., and Wittrup K.D. Improved mutants from directed evolution are biased to orthologous substitutions. Protein Eng Des Sel 19 (2006) 245-253
21. Buonpane R.A., Moza B., Sundberg E.J., and Kranz D.M. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1. J Mol Biol 353 (2005) 308-321
22. Weber K.S., Donermeyer D.L., Allen P.M., and Kranz D.M. Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proc Natl Acad Sci USA 102 (2005) 19033-19038. In this study, a panel of higher-affinity mutants of a class II-restricted TCR was generated, found to retain exquisite peptide specificity, and used to address the functional consequences of TCR affinity on T cell activation.
23. Buonpane R.A., Churchill H.R.O., Moza B., Sundberg E.J., Peterson M.L., Schlievert P.M., and Kranz D.M. Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med 13 (2007) 725-729. This study describes the affinity maturation of a TCR V domain against the superantigen staphylococcal enterotoxin B (SEB). A mutant possessing a three-million-fold increase in binding affinity was isolated and found to potently antagonize lethal SEB activity in animal models.
24. Shusta E.V., Kieke M.C., Parke E., Kranz D.M., and Wittrup K.D. Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency. J Mol Biol 292 (1999) 949-956
25. d. J Biol Chem 281 (2006) 25734-25744
26. Piatesi A., Howland S.W., Rakestraw J.A., Renner C., Robson N., Cebon J., Maraskovsky E., Ritter G., Old L., and Wittrup K.D. Directed evolution for improved secretion of cancer-testis antigen NY-ESO-1 from yeast. Protein Expr Purif 48 (2006) 232-242
27. Kim Y.-S., Bhandari R., Cochran J.R., Kuriyan J., and Wittrup K.D. Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast. Proteins Struct Funct Bioinformatics 62 (2006) 1026-1035
28. Park S., Xu Y., Stowell X.F., Gai F., Saven J.G., and Boder E.T. Limitations of yeast surface display in engineering proteins of high thermostability. Protein Eng Des Sel 19 (2006) 211-217
29. Wentz A.E., and Shusta E.V. A novel high-throughput screen reveals yeast genes that increase secretion of heterologous proteins. Appl Environ Microbiol 73 (2007) 1189-1198
30. Rakestraw J.A., Baskaran A.R., and Wittrup K.D. A flow cytometric assay for screening improved heterologous protein secretion in yeast. Biotechnol Prog 22 (2006) 1200-1208
31. Chao G., Cochran J.R., and Dane Wittrup K. Fine epitope mapping of anti-epidermal growth factor receptor antibodies through random mutagenesis and yeast surface display. J Mol Biol 342 (2004) 539-550. This study details the application of yeast surface display for identifying key residues mediating protein-protein interactions. By constructing a library of randomly mutagenized EGFR variants and screening with anti-EGFR antibodies, the authors mapped the binding epitopes of these antibodies with residue resolution. Significantly, this technique identifies discontinuous and heat-denaturable epitopes, samples substitutions to amino acids other than alanine, and requires no soluble expression and purification of mutants.
32. Oliphant T., Engle M., Nybakken G.E., Doane C., Johnson S., Huang L., Gorlatov S., Mehlhop E., Marri A., Chung K.M., et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile Virus. Nat Med 11 (2005) 522-530. This study applies yeast surface display for determining the antigenic epitopes recognized by a panel of monoclonal antibodies specific for the envelope protein of West Nile Virus. Significantly, the epitope map of antibody E16 has been validated by crystallographic data, presented in Nybakken et al.
33. Nybakken G.E., Oliphant T., Johnson S., Burke S., Diamond M.S., and Fremont D.H. Structural basis of West Nile Virus neutralization by a therapeutic antibody. Nature 437 (2005) 764-769
34. Gould L.H., Sui J., Foellmer H., Oliphant T., Wang T., Ledizet M., Murakami A., Noonan K., Lambeth C., Kar K., et al. Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile Virus. J Virol 79 (2005) 14606-14613
35. Oliphant T., Nybakken G.E., Engle M., Xu Q., Nelson C.A., Sukupolvi-Petty S., Marri A., Lachmi B.-E., Olshevsky U., Fremont D.H., et al. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol 80 (2006) 12149-12159
36. Chung K.M., Nybakken G.E., Thompson B.S., Engle M.J., Marri A., Fremont D.H., and Diamond M.S. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc γ receptor-dependent and -independent mechanisms. J Virol 80 (2006) 1340-1351
37. Levy R., Forsyth C.M., LaPorte S.L., Geren I.N., Smith L.A., and Marks J.D. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. J Mol Biol 365 (2007) 196-210
38. + T cells. J Immunol 174 (2005) 3377-3385
39. Liang Y., Wan Y., Qiu L.-W., Zhou J., Ni B., Guo B., Zou Q., Zou L., Zhou W., Jia Z., et al. Comprehensive antibody epitope mapping of the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus: insight into the humoral immunity of SARS. Clin Chem 51 (2005) 1382-1396
40. Wang X.X., and Shusta E.V. The use of scFv-displaying yeast in mammalian cell surface selections. J Immunol Methods 304 (2005) 30-42. This study describes a method for screening yeast-displayed libraries by monolayer panning, which is well suited for engineering of proteins whose binding targets are not readily solubilized and expressed by adherent cells.
41. Richman S.A., Healan S.J., Weber K.S., Donermeyer D.L., Dossett M.L., Greenberg P.D., Allen P.M., and Kranz D.M. Development of a novel strategy for engineering high-affinity proteins by yeast display. Protein Eng Des Sel 19 (2006) 255-264. This study describes a method for screening yeast-displayed libraries by density centrifugation, which is well suited for engineering proteins whose binding targets are not readily solubilized and expressed by cells grown in suspension.
42. Peelle B.R., Krauland E.M., Wittrup K.D., and Belcher A.M. Design criteria for engineering inorganic material-specific peptides. Langmuir 21 (2005) 6929-6933
43. Krauland EM, Peelle BR, Wittrup KD, Belcher AM: Peptide tags for enhanced cellular and protein adhesion to single-crystalline sapphire. Biotechnol Bioeng 2007:n/a.
44. Kuroda K., and Ueda M. Effective display of metallothionein tandem repeats on the bioadsorption of cadmium ion. Appl Microbiol Biotechnol 70 (2006) 458-463
45. Furukawa H., Tanino T., Fukuda H., and Kondo A. Development of novel yeast cell surface display system for homo-oligomeric protein by coexpression of native and anchored subunits. Biotechnol Prog 22 (2006) 994-997
46. Shibasaki S., Kawabata A., Ishii J., Yagi S., Kadonosono T., Kato M., Fukuda N., Kondo A., and Ueda M. Construction of a novel synergistic system for production and recovery of secreted recombinant proteins by the cell surface engineering. Appl Microbiol Biotechnol 75 (2007) 821-828
47. l I domain mutants decorrelated from binding affinity. J Mol Biol 360 (2006) 37-44
48. Zhu K., Chi Z., Li J., Zhang F., Li M., Yasoda H.N., and Wu L. The surface display of haemolysin from vibrio harveyi on yeast cells and their potential applications as live vaccine in marine fish. Vaccine 24 (2006) 6046-6052
49. Tamaru Y., Ohtsuka M., Kato K., Manabe S., Kuroda K., Sanada M., and Ueda M. Application of the arming system for the expression of the 380R antigen from Red Sea Bream Iridovirus (RSIV) on the surface of yeast cells: a first step for the development of an oral vaccine. Biotechnol Prog 22 (2006) 949-953
50. Wadle A., Held G., Neumann F., Kleber S., Wuellner B., Asemissen A.M., Kubuschok B., Scheibenbogen C., Breinig T., Meyerhans A., et al. Cross-presentation of HLA Class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiae. Vaccine 24 (2006) 6272-6281
51. Shiraga S., Kawakami M., Ishiguro M., and Ueda M. Enhanced reactivity of Rhizopus oryzae lipase displayed on yeast cell surfaces in organic solvents: potential as a whole-cell biocatalyst in organic solvents. Appl Environ Microbiol 71 (2005) 4335-4338
52. Shiraga S., Ishiguro M., Fukami H., Nakao M., and Ueda M. Creation of Rhizopus oryzae lipase having a unique oxyanion hole by combinatorial mutagenesis in the lid domain. Appl Microbiol Biotechnol 68 (2005) 779-785
53. Parthasarathy R., Bajaj J., and Boder E.T. An immobilized biotin ligase: surface display of Escherichia coli BirA on Saccharomyces cerevisiae. Biotechnol Prog 21 (2005) 1627-1631
54. Takayama K., Suye S.-I., Kuroda K., Ueda M., Kitaguchi T., Tsuchiyama K., Fukuda T., Chen W., and Mulchandani A. Surface display of organophosphorus hydrolase on Saccharomyces cerevisiae. Biotechnol Prog 22 (2006) 939-943
55. Breinig F., Diehl B., Rau S., Zimmer C., Schwab H., and Schmitt M.J. Cell surface expression of bacterial esterase a by Saccharomyces cerevisiae and its enhancement by constitutive activation of the cellular unfolded protein response. Appl Environ Microbiol 72 (2006) 7140-7147
56. Zhang H.-C., Bi J.-Y., Chen C., Huang G.-L., Qi Q.-S., Xiao M., and Wang P.G. Immobilization of UDP-galactose 4-epimerase from Escherichia coli on the yeast cell surface. Biosci Biotechnol Biochem 70 (2006) 2302-2306
57. Shim J.-H., Seo N.-S., Roh S.-A., Kim J.-W., Cha H., and Park K.-H. Improved bread-baking process using Saccharomyces cerevisiae displayed with engineered cyclodextrin glucanotransferase. J Agric Food Chem 55 (2007) 4735-4740
58. Kadonosono T., Kato M., and Ueda M. Metallopeptidase, neurolysin, as a novel molecular tool for analysis of properties of cancer-producing matrix metalloproteinases-2 and -9. Appl Microbiol Biotechnol 75 (2007) 1285-1291
59. Ho M., Nagata S., and Pastan I. Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proc Natl Acad Sci USA 103 (2006) 9637-9642
60. Hamilton S.R., Bobrowicz P., Bobrowicz B., Davidson R.C., Li H., Mitchell T., Nett J.H., Rausch S., Stadheim T.A., Wischnewski H., et al. Production of complex human glycoproteins in yeast. Science 301 (2003) 1244-1246
61. Rao B.M., Driver I., Lauffenburger D.A., and Wittrup K.D. High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth. Biochemistry 44 (2005) 10696-10701
62. Boder E.T., Midelfort K.S., and Wittrup K.D. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc Natl Acad Sci USA 97 (2000) 10701-10705
63. Huang D., and Shusta E.V. Secretion and surface display of green fluorescent protein using the yeast Saccharomyces cerevisiae. Biotechnol Prog 21 (2005) 349-357
64. Boder E.T., Bill J.R., Nields A.W., Marrack P.C., and Kappler J.W. Yeast surface display of a noncovalent MHC class II heterodimer complexed with antigenic peptide. Biotechnol Bioeng 92 (2005) 485-491
65. Guex N., and Peitsch M.C. Swiss-model and the swiss-pdbviewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723